Project Grant R01NS138258
Award Date
4/21/25
Completion Date
3/31/30
Dollars Obligated
$656K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $501,985.34 to the University of Arkansas to conduct research on the structural consequences of protein kinase C (PKC)-dependent phosphorylation of the Kv7.2 ion channel. The research aims to elucidate how phosphorylation affects the binding of critical signaling cofactors like calmodulin and phosphatidylinositol 4,5-bisphosphate to the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to elucidate the structural pharmacology and therapeutic potential of GIRK channel disease mutants linked to Keppen-Lubinsky syndrome (KLS). The $525,436 award to the Icahn School of Medicine at Mount Sinai supports a multidisciplinary investigation to: 1) determine the...
This $877,447 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) aims to develop therapeutic approaches for a KCNQ3 gain-of-function neurodevelopmental disorder. The key products and services to be delivered include: 1) Developing novel microRNA (miKCNQ3) expression systems to restrict KCNQ3 gene expression in target neuronal populations...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research to investigate electrical signaling within the dendritic branches of spiny projection neurons in the basal ganglia. The $457,875 award, spanning July 2024 to June 2026, aims to test two key hypotheses: 1) Observed physiological disparities between...
This federal Project Grant award, valued at $618,925.00 and effective from July 1, 2024 to May 31, 2029, is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The primary objectives of this grant are to: 1) Evaluate the efficacy of first-generation bispecific antibody-antisense oligonucleotide (BAB-ASO) conjugates for increasing neuronal expression of the...
This $689,689 federal Project Grant (R21NS135454) awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under their Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support the development and testing of novel adeno-associated virus (AAV) constructs to enable highly targeted genetic manipulation of specific neuronal populations. The key objectives are to: 1) Design and evaluate hybrid AAV constructs that combine miniaturized...
This $264,600 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to elucidate the mechanisms linking CBX1 gene variants to neurodevelopmental disorders. The project will utilize mouse models with patient-identified CBX1 variants to investigate the impact on gene expression, neurodevelopment, and behavior. The goal is to...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $242,310 to conduct research on the effects of the NR2E1 genetic mutation on neurogenesis. The award to Baylor College of Medicine in Houston, TX will fund a 26-month project to: 1) assess how the I385T mutation in the NR2E1 gene impacts its ligand binding and cofactor...
This federal Project Grant award, R21NS139087, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $452,375 award will support research at Columbia University to investigate the structural and functional characteristics of kainate receptors (KARs), a type of ionotropic glutamate receptor found in the central nervous system. Specifically, the research...
This $145,642 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the non-canonical roles of voltage-gated sodium channels (VGSCS) in neurodevelopmental epilepsy. The research project aims to use human induced pluripotent stem cell-derived brain organoids carrying clinically relevant SCN3A mutations to: 1)...